
About Me.
I am a highly experienced laboratory professional with a Master’s in Healthcare Administration and multiple ASCP certifications, including Medical Laboratory Science (MLS), Molecular Biology (MB), and Diplomate in Laboratory Management (DLM). I also hold a California Clinical Laboratory Scientist (CLS) license from CDPH. My extensive expertise includes test development, clinical laboratory operations, regulatory compliance, and quality management system. I specialize in guiding molecular laboratories of all sizes to achieve and sustain the highest standards of excellence and regulatory adherence, particularly within CLIA- and CAP-accredited settings.
Publication
Hammer, P. M., Momeni-Boroujeni, A., Kolin, D. L., Kingsley, L., Folkins, A., Geisick, R. L., ... & Howitt, B. E. (2025). POLE-Mutated Uterine Carcinosarcomas: A Clinicopathologic and Molecular Study of 11 Cases. Modern Pathology, 38(3), 100676.
McHenry, A., Devereaux, K., Ryan, E., Chow, S., Allard, G., Ho, C. C., ... & Howitt, B. E. (2024). Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low‐and high‐stage tumours. Histopathology.
Hammer, P. M., Wang, A., Vermij, L., Zdravkovic, S., Heilbroner, L., Ryan, E., ... & Howitt, B. E. (2024). Molecular Classification Outperforms Histologic Classification in Prognostication of High-grade Endometrial Carcinomas With Undifferentiated and Sarcomatous Components. The American Journal of Surgical Pathology, 10-1097.
Fei, F., Kunder, C. A., Ho, C., Zehnder, J. L., Tomasello, G., Fung, E., & Suarez, C. J. (2024). Diagnostic impact of RNA-based next-generation sequencing fusion panel for solid tumors: A single- institution experience. American Journal of Clinical Pathology, 161(4), 329-341.
Zhang, H., Chien, M., Hou, Y., Shomali, W., Brar, R.S., Ho, C., ... & Zehnder, J. L. (2023). Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutations. Blood Advances, 7(1), 190-194.
Tung, J. K., Jangam, D., Ho, C. C., Fung, E., Khodadoust, M. S., Kim, Y. H., ... & Zhang, B. M. (2023). Minimal/Measurable Residual Disease Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptor. The Journal of Molecular Diagnostics, 25(6), 331-341.
Devereaux, K. A., Steiner, D. F., Ho, C., Gomez, A.J., Gilks, B., Longacre, T. A., ... & Suarez, C. J.(2022). A multiplex SNaPshot assay is a rapid and cost-effective method for detecting POLE exonuclease domain mutations in endometrial carcinoma. International Journal of Gynecological Pathology, 41(6), 541-551.
Devereaux, K. A., Weiel, J. J., Pors, J., Steiner, D. F., Ho, C., Charu, V., ... & Howitt, B. E. (2022). Prospective molecular classification of endometrial carcinomas: institutional implementation, practice, and clinical experience. Modern Pathology, 35(5), 688-696.
Ho, C. C., Tung, J. K., Zehnder, J. L., & Zhang, B. M. (2021). Validation of a next-generation sequencing–based T-cell receptor gamma gene rearrangement diagnostic assay: transitioning from capillary electrophoresis to next-generation sequencing. The Journal of Molecular Diagnostics, 23(7), 805-815.
Gu, W., Talevich, E., Hsu, E., Qi, Z., Urisman, A., Federman, S., ... & Chiu, C. Y. (2021). Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids. Genome medicine, 13(1), 98.
Scott, G. D., Schrandt, C., Ho, C. C., Chung, M. C., Zhou, D., & Shi, R. Z. (2018). Interfacing complex laboratory instruments during a change to epic beaker. Journal of Pathology Informatics, 9(1), 24.
Conference Posters
Ho, C, “Elevating Clinical Molecular Laboratory Operations through Smartsheet-Driven Dynamic Scheduling”, Association for Molecular Pathology (2024).
Wang, L, “Implementation and Validation of Thrombosis Risk Factor Assay with MassARRAY System”, Association for Molecular Pathology (2024).
Ho, C, “Cost-Reduction of T Cell Receptor Rearrangement Diagnostic Testing Utilizing Low-Depth Sequencing Strategy”, Association for Molecular Pathology (2024).
Wadsworth, P.A, “Amplicon-Based Nanopore Sequencing of Hemoglobin Genes for Diagnosis of Thalassemia”, Association for Molecular Pathology (2024).
Tong, A, “A retrospective study of Sanger sequencing reduction in clinical genetic testing based on whole genome sequencing”, American Society of Human Genetics (2024).
Wadsworth, P.A, “Evaluation of T Cell Immunotranscriptomic Profiling in Lymphoid Neoplasms”, Association for Molecular Pathology (2024).
Yu, J, “Tumor classification and deconvolution in liquid biopsy using enriched methylation sequencing”, American Association for Cancer Research (2024).
Ho, C, “Using genotyping-based Mendelian error analysis to identify and minimize the risk of sample misidentification in trio exome sequencing service”, Association for Molecular Pathology (2023).
Ho, C, “Performance Evaluation of a Next-Generation Sequencing-Based T-Cell Receptor Gene Rearrangement Assay”, Association for Molecular Pathology (2023).
Yang, C, “Molecular diagnosis and treatment guidance of EGFR-positive metastatic non-small cell lung adenocarcinoma from pleural effusion cell-free DNA targeted sequencing”, Association for Molecular Pathology (2023).
Wiredja, D, “Impact of Down-sampling T-Cell Receptor Sequencing Reads on Clonality Interpretation”, Association for Molecular Pathology (2023).
Qiao, W, “Clinical implementation of carrier screening and diagnostic testing for spinal muscular atrophy using PCR/capillary electrophoresis assay”, American College of Medical Genetics and Genomics (2023).
Chen, S, “Rapid Detection of Pathogenic UBA1 Variants by MassARRAY in Patients with VEXAS Syndrome”, Association for Molecular Pathology (2022).
Ho, C, “Clinical Validation of Anchored Multiplex PCR-Based Next-Generation Sequencing of Gene Fusions in Solid Tumors and Sarcomas”, Association for Molecular Pathology (2022).
Jangam, D, “A custom bioinformatics pipeline and database for T-cell receptor clonality and MRD data analysis in a clinical laboratory”, Association for Molecular Pathology (2022).
Hammond, N, “Clinical long-read genome sequencing: Analytical performance of germline small variant detection using HiFi genome sequencing”, American Society of Human Genetics (2022).
Dumas, K, “Development and Clinical Implementation of Genome-based Germline Exome Testing Development and analytical validation of an innovative 397 gene genome-based inherited kidney disease panel”, American Society of Human Genetics (2022).
Ho, C, “Utilization of Agena massARRAY to improve quality assessment of saliva samples for clinical genome sequencing”, American Society of Human Genetics (2022).
Tung, J “Assessment of a High-Throughput Sequencing Assay for Measurable Residual Disease (MRD) Monitoring in Patients with T-Cell Malignancies”, Association for Molecular Pathology (2020).
Jangam, D, “Database for Managing Results of High-Throughput Sequencing Clonality Assays in Clinical Laboratories”, Association for Molecular Pathology (2020).
Ho, C, “Comparison of Next-Generation Sequencing-Based TRG and TRB Assays for the Diagnostic Evaluation of T Cell Lymphoid Malignancies”, Association for Molecular Pathology (2020).
Devereaux, K, “Molecular Classification of Metastatic and Recurrent Endometrial Endometroid Carcinoma”, United States and Canadian Academy of Pathology (2020).
Ho, C, “Clinical Validation of an NGS-Based IGHV Somatic Hypermutation Assay”, Association for Molecular Pathology (2019).
Book Chapters
Wadsworth, P. A., Ho, C. C., & Zhang, B. M. (2024). Immunoglobulin and T‐Cell Receptor Gene Assessment. Manual of Molecular and Clinical Laboratory Immunology (9th edition), 1, 23-38.